Sodium intake across the world is now at an all-time high, whether it be in. A high-income or a low-income country. The primary source of this high-sodium diet is packed and processed food, which, even in a single big serving, can raise sodium levels more than the recommended daily amount. Increased sodium consumption is an…
To answer this question, I of course asked different AIs what the answer would be. Their responses: ChatGPT. In 2025, AI will significantly enhance healthcare by improving diagnostic accuracy, such as detecting early-stage cancers through tools like AI-enhanced mammograms and identifying retinal diseases via AI-analyzed optical scans. Personalized medicine will advance as AI tools like…
National Cancer Institute funding to help establish the Virginia Advancing Cancer Control Equity Research Through Transformative Solutions (VA-ACCERT) Center
Pfizer is walking away from partner Sangamo Therapeutics ahead of expected regulatory submissions for the hemophilia A gene therapy they co-developed. Cash-strapped Sangamo said it is now looking for a new partner for the program. The post Pfizer Ends Sangamo Alliance With Gene Therapy for Hemophilia on Cusp of FDA Filing appeared first on MedCity…
Amid the chaos and confusion of healthcare IT in our age of AI, a triage concept may be the best guide for organizations fighting to stray strong and capable in 2025 and beyond. The post Healthcare IT in 2025: Triage for the Age of AI appeared first on MedCity News.
Medicaid and CHIP facilitate necessary access to oral health services, which helps to bridge the gap in dental care for children from low- and moderate-income families. By providing coverage, it ensures that socioeconomic status does not hinder a child’s ability to receive necessary dental services. The post The Evolving Landscape of Medicaid and CHIP: Implications…
What were the most popular posts on Healthcare Economist this year? Here are the top 10 in descending order: Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best PracticesThe world is relying on the United States to get value-based drug pricing rightWhy is the market design for innovative…
In the US, opioid abuse has become and epidemic. However, in the past year, there is some hope that this epidemic is starting to reverse. Opioid deaths have fallen by 16.9% in the past year. Why have deaths fallen? According to The Economist, no one is sure: One possibility is a supply shock…the amount of…
December saw a slew of executive hires, promotions, exits and layoffs across the healthcare industry. For example, companies like Humana and Mayo Clinic hired new C-suite leaders, organizations including Atlantic Health System and Amwell are saying goodbye to key executives, and firms like CVS Health and Optum announced rounds of job cuts. The post Healthcare…
One Phase 3 test of Auvelity met its main goal in Alzheimer’s agitation while the drug’s other pivotal trial showed numerical improvement that fell short of statistical significance. Axsome Therapeutics aims to offer an alternative to Rexulti, a Lundbeck and Otsuka Pharmaceutical product that is the only FDA-approved Alzheimer’s agitation drug. The post Axsome Aims…